Cross-sell, made concrete

Do we even have enough overlap across our portfolio to justify a formal cross-sell motion?

Most PE deal teams overestimate portfolio overlap and miss cross-sell targets by 20%. Here's how to measure real customer overlap before launching a formal motion.

How do I actually track and measure a cross-sell pipeline that spans multiple portfolio companies?

Track cross-sell pipelines across portfolio companies with one of three models — centralized, decentralized, or hybrid — plus shared definitions and clean account data.

How do I assess customer overlap across targets during diligence before we've even closed the deal?

Assess customer overlap before closing a deal using clean-team analytics and account-level matching, not the top-down revenue estimates that hide double-counted accounts.

How do I defend our cross-sell ROI numbers when the board asks what's actually attributable to the program?

Defend cross-sell ROI to the board with multi-touch attribution tied to customer lifetime value, replacing single-touch models that collapse under scrutiny.

How do I evaluate pricing on cross-sell AI tools without paying for capability we don't need across the portfolio?

Evaluate cross-sell AI pricing by matching usage- or capacity-based models to real portfolio needs, instead of overpaying for bundled features you won't use.

How do I find which portfolio companies actually have complementary products worth cross-selling?

Find genuinely complementary portfolio products by mapping customer usage data and buying overlap, not the surface-level category adjacency that inflates forecasts.

How do I get warm intros happening across our portfolio without relying on the CEOs to remember to do it?

Scale warm introductions across your portfolio with structured, self-serve tools and tracked ownership, instead of relying on CEOs to remember every ask.

How do I identify ICP overlap across our portfolio companies without a six-month consulting engagement?

Identify ICP overlap across portfolio companies in weeks using standardized definitions and AI scoring — no six-month consulting engagement required.

How do I know an AI tool won't create data-sharing risk across our portfolio companies?

Vet an AI tool's data-sharing risk portfolio-wide, not company by company, by auditing agent permissions, security policies, and cross-entity data flows.

How do I know if cross-sell synergies across our portfolio are real or just a pitch deck slide?

Cross-sell synergies are real only when pipeline, win rates, and deal sizes shift in specific accounts — not when they exist only in a spreadsheet or slide.

How do I measure ROI on an AI-driven cross-sell program across the portfolio?

Measure ROI on an AI-driven cross-sell program by tracking incremental revenue, margin lift, and customer lifetime value, not backward-looking closed-revenue metrics.

How do I pilot cross-sell AI across two portfolio companies before rolling it out to the whole portfolio?

Pilot cross-sell AI across two portfolio companies with a 60-90 day test, clear metrics, and a risk framework before deciding whether to scale portfolio-wide.

How do I prove to the board that our portfolio cross-sell strategy is working

Prove portfolio cross-sell is working with attach rates, revenue contribution, and CLV uplift — the board-ready metrics that replace vague activity charts.

Is agentic AI actually useful for running cross-portfolio operations or is that overkill for us?

Agentic AI can run cross-portfolio operations, but only after you fix coordination, ownership, and data gaps first — otherwise it just amplifies existing flaws.

Who actually needs to be in the room before we buy an AI tool for cross-portfolio selling?

Buying an AI tool for cross-portfolio selling needs GTM, RevOps, finance, data, security, legal, and procurement in the room — not just IT or a single CRO.